NAD+ Therapy: Who It May Fit, What to Monitor, and What to Ask First

# NAD+ Therapy: Who It May Fit, What to Monitor, and What to Ask First NAD+ therapy gets a lot of attention in longevity conversations, but good decisions come from clinical fit—not trend momentum. This guide helps you evaluate whether it may be appropriate to discuss with your clinician. ## Who it may fit (discussion-level) NAD+ may be considered in broader performance and wellness discussions when there is a clear objective and a plan for follow-up. It is not a one-size-fits-all intervention. ## What to clarify before starting 1. **Primary goal:** What specific outcome are we targeting? 2. **Baseline status:** Which labs or assessments should be captured first? 3. **Safety profile:** Are there contraindications based on my history or current meds? 4. **Monitoring cadence:** How often should response and tolerability be reviewed? 5. **Stop/adjust rules:** What findings would change course? ## What to monitor - Objective markers chosen by your clinician - Symptom changes over a defined window - Tolerability and side-effect profile - Whether the protocol is producing meaningful, measurable benefit ## Avoid common mistakes - Starting without baseline measurements - Expecting guaranteed outcomes - Treating anecdotal claims as clinical proof - Skipping follow-up because early signals feel positive ## Bottom line NAD+ therapy should be approached as a structured, clinician-guided decision with measurable checkpoints. If the plan is vague, the risk-adjusted quality is usually low. --- **Educational only.** This content is not medical advice and does not replace personalized clinician care.

NAD+ Therapy: Who It May Fit, What to Monitor, and What to Ask First.